Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
50.2M
-
Shares change
-
+2.19M
-
Total reported value, excl. options
-
$2.38B
-
Value change
-
+$105M
-
Put/Call ratio
-
3.52
-
Number of buys
-
80
-
Number of sells
-
-89
-
Price
-
$47.40
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2017
213 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2017.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.2M shares
of 101M outstanding shares and own 49.69% of the company stock.
Largest 10 shareholders include FMR LLC (6.78M shares), BlackRock Inc. (6.33M shares), Vanguard Group Inc (6.1M shares), STATE STREET CORP (2.55M shares), Hillhouse Capital Management, Ltd. (2.39M shares), EcoR1 Capital, LLC (2.05M shares), JANUS HENDERSON GROUP PLC (1.99M shares), FARALLON CAPITAL MANAGEMENT LLC (1.66M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.61M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.16M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.